KRT76 Antibody

Code CSB-PA012570LA01HU
Size US$166
Order now
Image
  • IHC image of CSB-PA012570LA01HU diluted at 1:400 and staining in paraffin-embedded human endometrial cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
  • Immunofluorescence staining of SH-SY5Y cells with CSB-PA012570LA01HU at 1:133, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) KRT76 Polyclonal antibody
Uniprot No.
Target Names
KRT76
Alternative Names
CK 2P antibody; CK-2P antibody; CK2P antibody; Cytokeratin 2P antibody; Cytokeratin-2P antibody; Cytokeratin2 antibody; Cytokeratin2P antibody; HUMCYT 2A antibody; HUMCYT2A antibody; K22O_HUMAN antibody; K2P antibody; K76 antibody; KB9 antibody; Keratin 2p antibody; Keratin 76 antibody; Keratin 76, type II antibody; Keratin antibody; Keratin type II cytoskeletal 2 oral antibody; Keratin-76 antibody; Keratin2p antibody; Keratin76 antibody; KRT 2B antibody; KRT 2P antibody; KRT 76 antibody; KRT2B antibody; KRT2P antibody; KRT76 antibody; type II cytoskeletal 2 oral antibody; Type-II keratin Kb9 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Keratin, type II cytoskeletal 2 oral protein (173-283AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The KRT76 Antibody (Product code: CSB-PA012570LA01HU) is Non-conjugated. For KRT76 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA012570LB01HU KRT76 Antibody, HRP conjugated ELISA
FITC CSB-PA012570LC01HU KRT76 Antibody, FITC conjugated
Biotin CSB-PA012570LD01HU KRT76 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Tested Applications
ELISA, IHC, IF
Recommended Dilution
Application Recommended Dilution
IHC 1:200-1:500
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Probably contributes to terminal cornification.
Gene References into Functions
  1. Data shows that immunomodulatory role of Keratin 76 in oral and gastric cancer. PMID: 30143634
Protein Families
Intermediate filament family
Database Links

HGNC: 24430

OMIM: 616671

KEGG: hsa:51350

UniGene: Hs.654392

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*